- NORTH AMERICA EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
The entire North American Index now follows 43 publicly traded companies across all major Canadian and American public exchanges.
An index overlooking the North American public cannabis market added four new stocks to its list of constituents on Tuesday (April 24).
Described as overseeing the top-performing cannabis stocks in the US and Canadian markets, these two indexes will also create the overall North American Marijuana Index.
The companies that have been added to the index are as follows: General Cannabis (OTC:CANN); Liberty Health Sciences (CSE:LHS,OTCMKTS:LHSIF); Hiku Brands (CSE:HIKU,OTCMKTS:DJACF); and Isodiol International (CSE:ISOL,OTCMKTS:ISOLF).
These stocks will also be split into the Canadian and US indexes respectively. Hiku and Isodiol will join the Canadian index, while General Cannabis and Liberty Health will be added to the American one.
Index offers overall look into cannabis public market in North America
The entire North American Index now follows 43 publicly traded companies across all major Canadian and American public exchanges. The breakdown between the two indexes is 17 constituents for the Canadian one and 26 for the US index.
Due to the decline in Canadian cannabis stocks that has taken ahold of the industry since early this year, the Canadian index has seen a steady decline in its value so far in 2018. At the start of the trading year, the Canadian index was valued at 812.81 points.
On Tuesday, the Canadian Marijuana Index was valued at 625.7 points. On the other hand, the US index was valued at 88.58 points. At the start of the trading year, the US index was valued at 105.39 points.
According to the organizers, the minimum trading requirements for a company to join the index have been increased since the last quarter.
These restrictions now mandate for a company to reach a minimum market capitalization of US$80 million and a daily trading volume of US$2 million. The companies looking to be added to the index also need to have a share price of at least US$1.
Additionally, the index organizers state that companies with a revenue stream of over US$5 million the previous year are exempt from these rules.
Investor takeaway
Observers of the cannabis industry have a few options when it comes to tracking a large grouping of stocks. The performance from these informational indexes can give shareholders a superficial look into the overall performance of the sector.
Thanks to the distinction between the two indexes, investors can see differences between the two North American markets.
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
Editorial Disclosure: Isodiol International and Hiku Brands are clients of the Investing News Network. This article is not paid-for content.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.